本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Bionomics Limited

0.2531
0.0000
成交量:- -
成交额:268.28万
市值:494.24万
市盈率:-0.28
高:0.2531
开:0.2531
低:0.2531
收:0.2531
52周最高:1.60
52周最低:0.1770
股本:1,952.73万
流通股本:1,673.15万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.9166
每股收益(LYR):-1.5513
净资产收益率:-55.39%
总资产收益率:-41.41%
市净率:0.29
市盈率(LYR):-0.16

数据加载中...

2024/01/11

SEC问询函

Form CORRESP - Correspondence
2023/10/30

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/18

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/10/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/15

SEC问询函

Form CORRESP - Correspondence
2022/11/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/11/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/11/14

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/11/10

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/10/14

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/30

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/12/21

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/12/15

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/15

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/13

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/13

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/13

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/12/08

SEC问询函

CORRESP [Cover] - Correspondence